Analysis of blood coagulation in mice: Pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes

Thrombosis Journal

Volumn 3, Issue , 2005, Pages

  Sommeijer, Dirkje W ^a   van Oerle, René ^b   Reitsma, Pieter H ^a   Timmerman, Janneke J ^a   Meijers, Joost C M ^a   Spronk, Henri M H ^b   ten Cate, Hugo ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CITRATE SODIUM; HEPARIN; HEPARIN LYASE; POLYCLONAL ANTIBODY; THROMBIN ANTITHROMBIN COMPLEX;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; VALIDATION PROCESS;

EID: 27444441188     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-3-12     Document Type: Article

References (11)

1. Dorffler-Melly J, Schwarte LA, Ince C, Levi M: Mouse models of focal arterial and venous thrombosis. Basic Res Cardiol 2000, 95(6):503-509.
2. Kerlin B, Cooley BC, Isermann BH, Hernandez I, Sood R, Zogg M, Hendrickson SB, Mosesson MW, Lord S, Weiler H: Cause-effect relation between hyperfibrinogenemia and vascular disease. Blood 2004, 103(5):1728-1734.
3. Schafer K, Muller K, Hecke A, Mounier E, Goebel J, Loskutoff DJ, Konstantinides S: Enhanced thrombosis in atherosclerosisprone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 2003, 23(11):2097-2103.
4. Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA: A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Br J Haematol 1990, 74(4):471-479.
5. Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988, 59(1):101-106.
6. Manco-Johnson MJ, Nuss R, Jacobson LJ: Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices. J Lab Clin Med 2000, 136(1):74-79.
7. Lane DA, Caso R: Antithrombin: structure, genomic organization, function and inherited deficiency. Baillieres Clin Haematol 1989, 2(4):961-998.
8. Sugatani J, Igarashi T, Munakata M, Komiyama Y, Takahashi H, Komiyama N, Maeda T, Takeda T, Miwa M: Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2. Thromb Res 2000, 100(1):61-72.
9. Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ: Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993, 143(1):76-84.
10. Yamamoto K, Loskutoff DJ: Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996, 97(11):2440-2451.
11. Franco RF, de Jonge E, Dekkers PE, Timmerman JJ, Spek CA, van Deventer SJ, van Deursen P, van Kerkhoff L, van Gemen B, ten Cate H, van der Poll T, Reitsma PH: The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 2000, 96(2):554-559.